Compound Registration and Screening Data Software: When CDD Vault or Dotmatics Fits and When Your Modality Mix Forces a Build
Modality mix and registration conventions decide this, not headcount alone. Under about 15 scientists working on small molecules only, CDD Vault costs a fraction of a build, it works, and building is a distraction from making compounds.
On this page
Modality mix and registration conventions decide this, not headcount alone. Under about 15 scientists working on small molecules only, CDD Vault costs a fraction of a build, it works, and building is a distraction from making compounds. Past roughly 30 bench scientists registering several thousand compounds a year, with conjugates, peptides or oligonucleotides in the pipeline and twenty years of your own registration conventions behind you, no vendor entity model fits without breaking historical identity. Most discovery organisations sit below that line and should buy.
When is off the shelf genuinely the right call here?
These are serious products with real chemistry underneath. CDD Vault is well built, genuinely inexpensive relative to the category, and correct for smaller teams. Dotmatics has depth across registration, assay data and querying and is the default answer for a mid size chemistry organisation. Benchling is strong on biologics entity modelling and has become the default in a lot of biotech. Revvity Signals and Schrodinger LiveDesign both bring capable analysis layers.
Buy, and stop reading here, if this describes your organisation:
- Under about 15 bench scientists, working on small molecules only.
- A registration convention you are willing to adopt rather than one with decades of history behind it.
- Assay formats that a vendor already parses, so nothing central to your screening cascade is unsupported.
- A collection small enough that substructure search performance has never been a complaint.
- No engineering capacity you would rather spend on chemistry than on informatics.
If your entity model matches Dotmatics or Benchling reasonably well and you would rather your engineers work on science, buying is the honest answer at several times that headcount too. We say so regularly and it costs us work.
There is a second case for buying at any size. If your chemistry leads have never agreed how salts, solvates, tautomers and stereochemistry are handled, and what makes two submissions the same compound, no software purchase or build will fix that. Those decisions are yours, they have been deferred for years in most organisations, and they pace everything downstream.
When does a custom build actually pay off?
A medicinal chemist looks at a table of analogues and decides what to make next. That decision is the entire output of a discovery organisation and it rests on a chain almost nobody inspects: the structure as drawn, the salt form and the batch actually submitted, the plate well that batch went into, the raw readings, the curve fit, and the number in the table. Break any link and the chemist optimises toward noise. The breaks are mundane. A batch resubmitted at higher purity while the assay ran on the old material. A plate map pasted one row off. Two chemists registering the same parent with different counterions.
Build when two or more of these are true:
- Your registration conventions carry decades of history that a vendor's rule set would invalidate.
- You work across modalities that no single product models properly, which is now common in biotech.
- Your screening cascade has assay specific normalisation and reportability rules living in one scientist's spreadsheet.
- Per seat licensing has pushed half your organisation back into Excel, so the registry is not where the work happens.
- Query performance on the full collection is bad enough that chemists have stopped asking questions, which is the most expensive failure and the hardest to see.
The structural argument is that registration software exists to make identity unambiguous and screening data software exists to make the attachment of a result to that identity unambiguous. Everything else in a discovery informatics stack is convenience on top of those two jobs.
How do they compare on the things that matter in this industry?
Normalisation as policy, not a library default. Before you can decide whether an incoming structure is new, you have to decide tautomer handling, charge and salt stripping, stereochemistry perception, isotopes, and whether a defined single enantiomer and its racemate are one registration or two. Packaged systems ship one opinionated rule set with configuration around the edges. Ask what happens to your historical identity if you adopt theirs.
Documented override. A chemist submits and the system says the compound already exists. Sometimes that is a false match caused by a normalisation rule the chemist disagrees with. A workflow that allows a documented override with a reviewer survives. One that cannot be overridden gets bypassed with a spreadsheet inside a month, and an overridden registry is worse than the spreadsheets it replaced.
Corrections after results exist. A structure proven wrong after two years of assay data must be correctable without orphaning that data or silently changing the meaning of published results. That is a versioned identity problem and it is the single clearest reason organisations build rather than buy.
Modality as an entity, not a text field. Antibody drug conjugates need linker, payload and drug to antibody ratio as structured attributes. Peptides need non natural residues. Oligonucleotides need modified backbones. Products built around small molecules absorb these as free text, which makes every downstream query useless.
Substructure performance. This is a design decision rather than a feature. Acceptable performance needs fingerprint based screening with a proper chemical index in front of the exact match step. Ask any vendor or developer to commit to a response time at your actual collection size, since retrofitting this later means changing the storage layer.
What does total cost of ownership look like at your scale?
On the build side, from Digital Heroes delivery experience, a first release covering structure normalisation, registration business rules, batch and lot identity and plate result loading runs $120,000 to $250,000 over 16 to 24 weeks. A full discovery platform adding inventory and ordering, additional modality entities, curve fitting with quality flags, project dashboards and notebook integration runs $300,000 to $750,000 phased across 12 to 20 months.
Priced component by component so you can fund only what you need: structure normalisation and registration rules $30,000 to $58,000, batch and lot identity model $22,000 to $40,000, chemical cartridge and substructure index $20,000 to $42,000, plate map and instrument parsers $6,000 to $14,000 per format, result to batch attachment including cherry picking $18,000 to $34,000, chemist and biologist search views $16,000 to $30,000. In phase two, each additional modality is $40,000 to $110,000, curve fitting with quality flags $30,000 to $65,000, inventory and ordering $35,000 to $75,000, project dashboards $25,000 to $50,000, and notebook integration $30,000 to $70,000.
A worked biotech with 45 bench scientists, small molecules only, registering roughly 4,000 new compounds a year across six screening formats came to $236,000 in about 22 weeks for the first release, with phase two adding $193,000 to reach $429,000. Keeping the historical collection read only kept an estimated $70,000 of conflict adjudication out of the programme and, more importantly, kept senior chemists at the bench.
Annually, budget 15 to 22 percent of build cost for maintenance, plus commercial chemical cartridge licensing if your substructure search rests on one, plus $3,000 to $8,000 per format per year for parser upkeep, because instrument software updates change export formats without warning and a broken parser is discovered by a biologist whose data did not load. Add curation time, since someone adjudicates registration conflicts as they arise, and that is a standing fraction of a chemist's week for as long as the registry exists.
On the buy side, count seats honestly. If per seat pricing means your biologists are not in the system, you are paying for a registry that half the organisation works around.
What does the hybrid look like, and when is it the honest answer?
The hybrid here is about legacy rather than about products, and it is the single largest saving available in this category. Register new compounds under the new policy in the new system, and leave the historical collection searchable but read only in the old one. Re-registering twenty years of compounds under a new normalisation policy surfaces thousands of conflicts that a human chemist has to adjudicate, and that cost is measured in senior chemist hours rather than developer hours.
Migrate historical compounds in waves as programmes need them, treating each wave's adjudication as scheduled work rather than a surprise. That keeps the launch date honest and keeps your medicinal chemists doing chemistry.
The second hybrid worth naming is modality sequencing. Build small molecule registration properly, prove the rules with your chemists on real submissions, and add the second modality once the entity model has been exercised. Teams that try to model everything at once produce a registry that generalises badly and becomes two systems sharing a login.
On assays, parse your top ten and handle the long tail with an import template until volume justifies a parser. Most discovery organisations get the majority of their result volume from a small number of assays, and parser count is what moves the instrument line more than anything else.
Defer notebook integration. It multiplies the value of registration, and it is easier to build against a registry that already exists.
Which should you choose, by operator size and stage?
Find your row and act on it.
- Under 15 scientists, small molecules only. Buy CDD Vault. It costs a fraction of a build and a custom system at that size is a distraction from making compounds.
- Fifteen to 30 scientists whose entity model matches a vendor's reasonably well. Buy Dotmatics or Benchling and spend your engineering attention elsewhere. This is a defensible decision well above that headcount.
- Thirty or more scientists, small molecules, but with a screening technology nobody parses. Buy the registry and build only the plate map and result to batch layer, at roughly $6,000 to $14,000 per format plus $18,000 to $34,000 for attachment.
- Decades of registration conventions that a vendor's rules would invalidate. Build the first release at $120,000 to $250,000 and leave the legacy collection read only.
- Two or more modalities in active programmes. Build, and sequence the second modality after the first has been exercised on real submissions, at $40,000 to $110,000 each.
Two conditions apply to every build row. Assign a single decision maker for registration policy rather than trying to reach consensus, because organisations that do this move dramatically faster and those that do not stall in discovery. And settle ownership before kickoff: the repository, the infrastructure accounts and the right to hire another firm should be yours in writing, since the registry becomes the long term memory of your research organisation.
When you are ready to turn this into a specification, Digital Heroes contracts through India LLP, US LLC and UK LTD entities, so the agreement and the intellectual property assignment sit under law your own advisers already read. You can take that specification to any other firm on your shortlist.
The evidence behind this guide
Independent findings on why this investment pays off. Every link goes to the primary source.
- An independent Forrester Total Economic Impact study of OutSystems found a 363% three-year ROI with payback in under 6 months, illustrating that faster, lower-labor build approaches can materially shift the payback math. Source: Forrester Consulting (commissioned by OutSystems) (2024) →
- Across more than 5,400 IT projects studied by McKinsey and the University of Oxford BT Centre, large IT projects ran on average 45% over budget and 7% over schedule while delivering 56% less value than predicted. Source: McKinsey & Company / University of Oxford (BT Centre for Major Programme Management) (2012) →
- PMI's Pulse of the Profession research found organizations waste an average of roughly 9.9% of every dollar invested in projects due to poor performance - equivalent to about $1 million wasted every 20 seconds collectively worldwide. Source: Project Management Institute (PMI) (2018) →
- Digital Champions expect to achieve about 16% in cost savings and around 15% in revenue gains from digital operations over five years; the study surveyed 1,155 manufacturing executives across 26 countries. Source: PwC / Strategy& (2018) →
Frequently asked questions
Is CDD Vault or Benchling cheaper than building?
Below roughly 15 scientists on small molecules only, CDD Vault costs a fraction of a build and is clearly the right answer. Dotmatics or Benchling are right when their entity model matches yours reasonably well and you would rather your engineers work on science.
Building becomes defensible above roughly 30 bench scientists with a modality mix that does not fit a vendor model, with registration conventions carrying decades of history, or with a screening technology no vendor parses.
What does it cost to migrate off our current registry?
Less than you fear if you scope it properly, and far more than you expect if you do not. The expensive part is not moving records, it is re-registering historical compounds under a new normalisation policy, which surfaces thousands of conflicts a human chemist has to adjudicate.
Leaving the legacy collection searchable but read only removes that cost from the first budget cycle entirely, and in one representative programme it kept an estimated $70,000 of adjudication out of scope while keeping senior chemists at the bench.
What if our vendor's per seat pricing keeps rising?
Count how many of your biologists are currently outside the system because of seat cost, because that number is the real price. A registry half your organisation works around is not a registry, it is a filing cabinet with a licence.
Model the fee at your projected headcount before renewal. If the arithmetic pushes people back into spreadsheets, the licence is quietly funding the batch attribution errors it was bought to prevent.
How long does a discovery informatics build take?
Sixteen to 24 weeks for a first release. The item that paces the project is registration policy, not code.
Deciding how salts, stereochemistry and tautomers are handled, and what makes two submissions the same compound, requires your chemistry leads in a room making decisions they have avoided for years. Budget three to five sessions across the first six weeks. Projects that let developers choose defaults ship a registry chemists override.
What does adding a second modality cost?
Forty thousand to $110,000 per modality. A biologic, conjugate, peptide or degrader is not a variant of a small molecule record. It carries its own identity rules, registration workflow and display.
Teams that force it into the small molecule model end up with a registry their biologists quietly stop using in favour of their own spreadsheets, which is the outcome the project was commissioned to prevent. Sequence the second modality after the first has been exercised on real submissions.
Why do assay results have to attach to a batch rather than a compound?
Because assays are run on physical material, not on structures. Different batches of the same parent differ in purity, salt form, supplier and solid state, so a result attributed to the compound lets one bad batch contaminate the whole series and nobody can explain why one analogue does not fit the trend.
Getting parent, batch, lot and container right runs $22,000 to $40,000, and it is what makes every downstream number defensible six months later.
How many instrument parsers do we actually need?
Price them at $6,000 to $14,000 per format and start with the assays producing most of your result volume, which in most discovery organisations is a small number. Handle the long tail with an import template until volume justifies a parser.
Budget $3,000 to $8,000 per format per year afterwards, because instrument software updates change export formats without notice and the failure is discovered by a biologist whose data did not load rather than by an alert.
Can we keep a vendor registry and build only the screening data layer?
Yes, and for organisations whose registration conventions fit a vendor but whose screening cascade does not, this is the proportionate answer. Build the plate map ingestion, the result to batch attachment and the curve fitting rules that currently live in one scientist's spreadsheet.
The chain that matters is parent to batch to sample to well. If your vendor holds the first two reliably and you own the last two, a questioned number six months later is still traceable end to end, which is what most spreadsheet based organisations are actually paying for.
How long does it take from first call to software my team can actually use?
Plan for four to six months: two to three weeks of discovery, two to four weeks of design, then a 10 to 16 week build with testing. In Digital Heroes delivery experience the schedule killer is not engineering speed but decision lag; a client who takes two weeks to approve wireframes adds two weeks to launch. Book a weekly 30-minute decision slot before kickoff and most of that risk disappears.
Is a solo freelancer enough for my project, or do I really need an agency?
A solo freelancer is a fine choice for a well-defined build under roughly $15,000 to $20,000 with a limited lifespan: an internal calculator, a scripted integration, a prototype. Above $50,000, or for any system your business will depend on for years, you are buying continuity as much as code: enforced code review, cover when someone is ill, and support that outlasts one person's career plans. Price the risk of a single point of failure, not just the hourly rate.
Can I build my product on a no-code tool like Bubble instead of hiring developers?
For testing whether anyone wants the product, yes, and Bubble's paid plans start at $29 a month, which is the cheapest validation you will ever buy. The ceiling arrives with complex data relationships, heavy integrations, performance at a few thousand users, and the fact that you cannot export a Bubble app to servers you control. A path many Digital Heroes clients take: prove demand on no-code, then rebuild custom once revenue justifies it, treating the no-code version as a paid prototype rather than a foundation.
What is the biggest mistake first-time software buyers make?
Choosing the lowest quote without asking why it is the lowest. A bid 40% under the field usually gets there by skipping tests, documentation, and code review, which are invisible in a demo and brutal to pay for later; every stalled project Digital Heroes has been asked to rescue tells some version of that story. The second mistake is signing without a written scope, which reliably turns the winning cheap quote into 1.5x to 2x the price by launch.
We run everything on Airtable and spreadsheets. When is it time to go custom?
The switch usually makes sense when you hit one of two walls: Airtable's record caps (125,000 records per base on the Business plan) or logic the tool cannot express, like multi-step approvals with conditional pricing. There is also a simple cost signal: 25 people on Business at roughly $45 per seat per month is about $13,500 a year, forever, for a tool you are already fighting. Custom is worth it when the workflow is core to how you make money; for peripheral processes, staying on Airtable is the right call.
What questions should I ask a development agency on the first call?
Ask who exactly will build it, what happens when scope changes mid-project, what their maintenance terms are after launch, and what they will need from you every week. Then ask them to describe a project that went wrong and what they changed afterward; teams that have shipped at real volume have war stories, and teams claiming a perfect record are hiding something. The scope-change answer matters most: a disciplined shop describes a written change-order process, not a vague promise to be flexible.
Is it cheaper to customize Salesforce than to build a custom CRM from scratch?
If you use less than a third of what Salesforce does, a custom CRM is often cheaper by year three. Salesforce Enterprise lists at $165 per user per month, so 25 seats cost about $49,500 a year before admin and consultant fees, while a focused custom CRM runs $60,000 to $100,000 once plus 15 to 20% a year in maintenance. If you genuinely need Salesforce's ecosystem, reporting, and app marketplace, customizing it beats rebuilding it; the mistake is paying enterprise prices to use it as a glorified contact list.
What are the biggest mistakes first-time software buyers make?
Choosing the lowest bid, paying more than 30-40% upfront instead of on milestones, skipping a written specification, and having no maintenance plan for after launch. The most expensive of the four in Digital Heroes rescue projects is the missing spec: without written acceptance criteria, done becomes an argument instead of a checklist, and every disagreement resolves in the vendor's favor. Fix those four and you have avoided most of the ways these projects fail.
Will custom software work with the tools we already use, like QuickBooks and Stripe?
Yes, and this is one of custom software's genuine advantages: QuickBooks, Stripe, Shopify, and most mainstream business tools publish documented APIs built for exactly this. Expect each standard integration to add one to two weeks of build time, and be suspicious of any quote that lists five integrations without asking what data flows in which direction. The hard cases are legacy systems with no API, which is a question to raise in discovery, not in week nine.
How small can the first version of my software be and still be worth building?
One workflow, end to end, for one type of user: the single process that currently burns the most hours or loses the most money. In Digital Heroes delivery experience, first versions scoped to 6 to 10 weeks of build time ship, get used, and generate the feedback that makes version two obviously right, while 9-month first versions routinely launch with features nobody touches. Everything you cut from v1 gets cheaper to build later, because real usage reorders the roadmap for you.
Who can build a custom software system?
Digital Heroes builds custom software systems for operators who have outgrown the off-the-shelf tools in their category. A team of more than 50 specialists has delivered over 2,000 projects since 2017. Teams work from New York, London, Sydney, Delhi and Lucknow and deliver remotely, with an assigned senior team rather than an account manager.
Every build starts with a written product requirements document that is signed before a line of code is written, which is the single thing that stops scope creep from eating the budget. Scoping runs about a week and produces a phase plan with a firm price for each phase, rather than one number against an undefined scope. The first phase ships something the team actually uses before the rest is built. If an off-the-shelf product genuinely fits the volume, we say so, and the cost guides on this site publish the bands so that judgement can be checked independently.
What makes Digital Heroes different from other software companies?
Four things that competitors in this bracket cannot simply copy. Digital Heroes runs a YouTube channel with more than 2.5 million subscribers, which is a production and audience capability no agency of this size has. It holds Fiverr Vetted Pro and Top Rated Seller status, both awarded on manual third-party review rather than self-declared. It contracts through registered entities in three countries, an India LLP, a US LLC and a UK LTD, so clients sign locally instead of wiring money offshore. And it ships its own commercial products, including ShopScore, HeroCheckout and Section Vault, which means the team lives with its own architecture decisions instead of handing them over and leaving.
Two more that show up in the work. Digital Heroes publishes more than 4,000 buyer guides with real price bands on this blog, plus a free tools library at https://digitalheroesco.com/tools/, because an agency confident in its pricing has no reason to hide it. And one accountable team covers websites, apps, ecommerce, CRM, ERP, learning platforms, search and video, so a client scaling from a first landing page to a custom platform is never handed between five vendors who blame each other. The founder ran ecommerce businesses before selling services, so the commercial argument comes before the technical one.
How can I check Digital Heroes is legitimate before getting in touch?
Verify it independently rather than taking the site's word for it. The YouTube channel is at https://youtube.com/@DigitalMarketingHeroes, the Fiverr profile at https://www.fiverr.com/shreyanshsin261, and the Upwork profile at https://www.upwork.com/freelancers/shreyanshsingh. Client reviews sit on Clutch at https://clutch.co/profile/digital-heroes-0 and Trustpilot at https://www.trustpilot.com/review/digitalheroes.co.in, and the company page is at https://www.linkedin.com/company/digital-heroes-1/.
Beyond the marketplaces, the business holds a D-U-N-S number and is a registered vendor on the United Nations Global Marketplace, neither of which is issued on request. Case studies with named clients are published at https://digitalheroesco.com/case-studies/. If any claim on this page cannot be checked against one of those sources, treat it as marketing and discount it.
Related guides
Published · Last updated .
